Outcomes of liver transplantation in the era of modern antiviral therapy for hepatitis C
The emergence of direct-acting antivirals (DAAs) has become the basis for a new potential treatment for chronic hepatitis C (CHC) in patients with decompensated cirrhosis, who previously had no other alternative than liver transplantation (LT). However, optimal timing of antiviral therapy (AVT) rema...
Saved in:
| Main Authors: | K. Yu. Kokina, Yu. O. Malinovskaya, Ya. G. Moysyuk |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Federal Research Center of Transplantology and Artificial Organs named after V.I.Shumakov
2021-04-01
|
| Series: | Вестник трансплантологии и искусственных органов |
| Subjects: | |
| Online Access: | https://journal.transpl.ru/vtio/article/view/1310 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Experience of enrollment and management of the Waiting list for liver transplantation at hepatological center
by: Ye. N. Bessonova, et al.
Published: (2013-12-01) -
Management of variceal bleeding in the liver transplant waiting list
by: V. L. Korobka, et al.
Published: (2021-01-01) -
POSSIBILITIES OF HEPATITIS C ANTIVIRAL TREATMENT IN LIVER TRANSPLANT RECIPIENTS
by: V. E. Syutkin, et al.
Published: (2011-06-01) -
Efficacy of direct-acting antivirals in patients with hepatitis C virus-associated cryoglobulinemic vasculitis: Results of a long-term follow-up
by: S. V. Gavrisheva, et al.
Published: (2023-04-01) -
HCV-related chronic kidney disease in the era of new direct-acting antivirals regimens
by: Jakub Janczura, et al.
Published: (2025-08-01)